ReviewBiomolecules2025
Synthetic Strategies for Bioactive Oligosaccharides.
Review in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Carbohydrates are essential constituents of numerous biological systems, playing key roles in fundamental processes such as cellular recognition and immunological responses, while also offering significant potential in medical diagnostics and pharmaceutical development. However, the structural complexity of naturally occurring carbohydrates-characterized by heterogeneous glycosylation patterns and diverse branching architectures-poses considerable challenges in the isolation and preparation of homogeneous oligosaccharide samples. Recent advances in synthetic chemistry have led to substantial progress in carbohydrate synthesis, with modern glycosylation methodologies achieving improved stereochemical control and enhanced reaction efficiency, thereby enabling the precise and programmable construction of biologically relevant oligosaccharides. This review provides a systematic evaluation of six major strategies for oligosaccharide assembly: One-pot synthesis strategy, orthoganal protection strategy, preactivation strategy, linear and convergent block strategy, programmable one-pot synthesis strategy, and solid-phase synthesis strategy. For each strategy, we examine the key technological innovations, representative applications, and current limitations. Furthermore, the review discusses emerging trends in the field, emphasizing the transformative role of intelligent automation and machine learning in accelerating the discovery and synthesis of complex carbohydrates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.